This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.

The ABN gratefully acknowledges the generous support of the following ABN Annual Sponsors for 2020.

Arvelle logo

Bringing innovative treatments to patients suffering from CNS disorders

AveXis logo

AveXis, a Novartis company, is the world’s leading gene therapy company, redefining the possibilities for patients and families affected by life-threatening genetic diseases through our innovative gene therapy platform. Founded in 2013 and headquartered in Bannockburn, USA, the goal of AveXis’ cutting-edge science is to address the underlying, genetic root cause of diseases. AveXis pioneered foundational research, establishing AAV9 as an ideal vector for gene transfer in diseases affecting the central nervous system, laying the groundwork to build a best-in-class, transformational gene therapy pipeline.

biogen logo

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, and is focused on potential therapies in neuromuscular, neurodegenerative, and ophthalmology disease areas. Biogen also believes that biosimilars, and their associated cost-savings, are central to safeguarding future healthcare. To learn more, please visit,

Celgene logo

More information coming soon

GW Pharma logo

More information soon

Novartis logo

Novartis UK is a leading medicines company powered by data and digital. Our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. Proud to be a leader within the life sciences industry in the UK, we develop breakthrough treatments and deliver them directly to the millions of people in the UK who need them.

Novartis Pharmaceuticals UK Limited

2nd Floor, The WestWorks Building

White City Place

195 Wood Lane

London W12 7FQ


General Enquiries:

Tel: +44 1276 692255

Fax: +44 1276 692508

Roche logo

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Roche in the UK employs over 2,000 people in pharmaceuticals and diagnostics.

Sanofi Genzyme logo

More information soon

Teva logo

We are Teva, a global pharmaceutical company specialising in medicines within the central nervous system and respiratory therapy areas. We’ve been around for about 80 years, which is longer than the NHS! We contribute to improving the lives and health of patients all around the UK. We’re the biggest supplier of medicines to the NHS* and a key partner to NHS organisations where we work together to improve healthcare outcomes for patients through joint working projects. *Data on file

Teva UK Limited, Ridings Point

Whistler Drive, Castleford WF10 5HX

01977 628500

Contact Us

Association of British Neurologists
Ormond House
27 Boswell Street

Telephone: +44 (0)20 7405 4060

Registered Charity No. 1077893
Company No. 3816842

Follow Us